Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 7/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | MTOR | P42345 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.90 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.87 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.87 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.87 |
| ▸ | BLM | P54132 | 1/20 | 0.87 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.87 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10835242 | 1.00 | TRPV1 (1.00) | TRPV1HPGDMAPTCYP1A2CYP3A4 | |
| SCHEMBL10710550 | 1.00 | TRPV1 (1.00) | TRPV1HPGDMAPTCYP1A2CYP3A4 | |
| SCHEMBL10711981 | 1.00 | TRPV1 (1.00) | TRPV1HPGDMAPTCYP1A2CYP3A4 | |
| Olvanil SCHEMBL557179 | 1.00 | TRPV1 (1.00) | TRPV1HPGDMAPTCYP1A2CYP3A4 | |
| Olvanil SCHEMBL94262 | 1.00 | TRPV1 (1.00) | TRPV1HPGDMAPTCYP1A2CYP3A4 | |
| SCHEMBL10713542 | 1.00 | TRPV1 (1.00) | TRPV1HPGDMAPTCYP1A2CYP3A4 | |
| SCHEMBL10711036 | 1.00 | TRPV1 (1.00) | TRPV1HPGDMAPTCYP1A2CYP3A4 | |
| Olvanil SCHEMBL29381897 | 1.00 | TRPV1 (1.00) | TRPV1HPGDMAPTCYP1A2CYP3A4 | |
| SCHEMBL10883574 | 0.98 | TRPV1 (0.96) | TRPV1HPGDMAPTCYP1A2CYP3A4 | |
| SCHEMBL10885299 | 0.98 | TRPV1 (0.96) | TRPV1HPGDMAPTCYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1414427-A4 | KAVALACTONE COMPOSITIONS AND METHODS OF USE | SYNTA PHARMACEUTICALS CORP (US) | 2004-08-18 | — | — | EP | claimed |
| EP-1414427-A2 | KAVALACTONE COMPOSITIONS AND METHODS OF USE | Kava Pharmaceuticals, Inc. (US) | 2004-05-06 | — | — | EP | claimed |
| US-20030105159-A1 | Kavalactone compositions and methods of use | SYNTA PHARMACEUTICALS CORP. | 2003-06-05 | — | — | US | claimed |
| WO-2003013436-A2 | KAVALACTONE COMPOSITIONS AND METHODS OF USE | KAVA PHARMACEUTICALS, INC. (US) | 2003-02-20 | — | — | WO | claimed |
| US-5762963-A | DISPERSING IN SOLID OR GEL VEHICLE IN WHICH CONCENTRATION OF CAPSAICINOID DECREASES FROM CENTER TOWARD PERIPHERY; FOR MOUTH, THROAT PAIN RELIEF | EMORY UNIVERSITY (US) | 1998-06-09 | — | — | US | claimed |
| WO-1996040079-A1 | METHOD AND COMPOSITIONS FOR CONTROLLING ORAL AND PHARYNGEAL PAIN USING CAPSAICINOIDS | EMORY UNIVERSITY (US) | 1996-12-19 | — | — | WO | claimed |
| EP-0306060-B1 | PHARMACEUTICAL PRODUCTS PROVIDING ENHANCED ANALGESIA | THE PROCTER & GAMBLE COMPANY (US) | 1992-08-19 | — | — | EP | claimed |
| EP-0149545-B1 | PHARMACEUTICAL PRODUCTS PROVIDING ENHANCED ANALGESIA | THE PROCTER & GAMBLE COMPANY (US) | 1989-12-27 | — | — | EP | claimed |
| EP-0149544-B1 | PHARMACEUTICAL PRODUCTS PROVIDING ENHANCED ANALGESIA | THE PROCTER & GAMBLE COMPANY (US) | 1989-09-13 | — | — | EP | claimed |
| US-4812446-A | CAPSAICINOID AND SALICYLATE | THE PROCTER & GAMBLE COMPANY (US) | 1989-03-14 | — | — | US | claimed |
| EP-0306060-A2 | Pharmaceutical products providing enhanced analgesia | THE PROCTER & GAMBLE COMPANY (US) | 1989-03-08 | — | — | EP | claimed |
| EP-0149545-A2 | Pharmaceutical products providing enhanced analgesia | THE PROCTER & GAMBLE COMPANY (US) | 1985-07-24 | — | — | EP | claimed |
| US-20220288164-A1 | METHOD TO INCREASE SYSTEMIC BLOOD PRESSURE IN SHOCK | GEORGETOWN UNIVERSITY | 2022-09-15 | — | — | US | disclosed |
| US-20210228511-A1 | NEURONAL AGONISTS AND ISOTONIC OR HYPERTONIC SALINE FOR TREATING RESPIRATORY DISEASES | UNIVERSITY OF SASKATCHEWAN (CA) | 2021-07-29 | — | — | US | disclosed |
| US-20190038573-A1 | ION CHANNEL ACTIVATORS AND METHODS OF USE | CLIFF-CARTWRIGHT CORPORATION | 2019-02-07 | — | — | US | disclosed |
| US-20180117004-A1 | SELECTIVE ABLATION OF PAIN-SENSING NEURONS BY ADMINISTRATION OF A VANILLOID RECEPTOR AGONIST | THE GOVERNMENT OF THE US SECRETARY OF THE DEPARTMENT OF (US) | 2018-05-03 | — | — | US | disclosed |
| EP-0132115-A1 | Novel compounds and compositions useful for producing analgesia | THE PROCTER & GAMBLE COMPANY (US) | 1985-01-23 | — | — | EP | disclosed |
| EP-0132114-A1 | Novel compounds and compositions useful for producing analgesia | THE PROCTER & GAMBLE COMPANY (US) | 1985-01-23 | — | — | EP | disclosed |
| EP-0132113-A1 | Compositions useful for producing analgesia | THE PROCTER & GAMBLE COMPANY (US) | 1985-01-23 | — | — | EP | disclosed |
| US-4493848-A | N-((SUBSTITUTED PHENYL)METHYL)CIS MONOUNSATURATED ALKENAMIDE) | THE PROCTER & GAMBLE COMPANY (US) | 1985-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210228511-A1 | NEURONAL AGONISTS AND ISOTONIC OR HYPERTONIC SALINE FOR TREATING RESPIRATORY DISEASES | CFTR, TRPV1, SLC18A3 | TRPV1 2/4885HPGD 1641/4885MAPT 762/4885 |
| US-20220288164-A1 | METHOD TO INCREASE SYSTEMIC BLOOD PRESSURE IN SHOCK | VASP, TRPV1, BDKRB2 | TRPV1 2/4885HPGD 1178/4885MAPT 3809/4885 |
| US-20180117004-A1 | SELECTIVE ABLATION OF PAIN-SENSING NEURONS BY ADMINISTRATION OF A VANILLOID RECEPTOR AGONIST | TRPV1, OPRL1, TRPV3 | TRPV1 1/4885HPGD 1023/4885MAPT 3925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.